Autres langues SUSMED,Inc.

Actions

4263

JP3319150003

Marché Fermé - Japan Exchange Autres places de cotation 08:00:00 17/05/2024			Varia. 5j.	Varia. 1 janv.
553 ^JPY	+4,93%		+2,03%	-58,58%

2022	Walgreens Boots Alliance, Inc. rejoint le partenariat Sustainable Medicines	CI
2022	Aculys Pharma et SUSMED concluent un contrat pour mener l'essai clinique en utilisant la technologie Blockchain	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

SUSMED,Inc.(TSE:4263) added to S&P Global BMI Index	18/09/23
DTx von SUSMED wurde in Japan für die Behandlung von Schlaflosigkeit zugelassen	25/08/23
SUSMED’s DTx Approved in Japan for the Treatment of Insomnia	25/08/23
Walgreens Boots Alliance, Inc. Joins Sustainable Medicines Partnership	04/10/22
Aculys Pharma und SUSMED schließen Vertrag über Durchführung von weltweit erster klinischer Studie mit Blockchain-Technologie	14/07/22
Aculys Pharma and SUSMED Have Entered into a Contract to Conduct the World's First Clinical Trial Utilizing Blockchain Technology	13/07/22
Aculys Pharma and SUSMED Enter into A Contract to Conduct the Clinical Trial Utilizing Blockchain Technology	13/07/22
Certain Common Stock of SUSMED,Inc. are subject to a Lock-Up Agreement Ending on 21-JUN-2022.	21/06/22
Certain Common Stock of SUSMED,Inc. are subject to a Lock-Up Agreement Ending on 23-MAR-2022.	23/03/22
CollaboCreate Co., Ltd. announced that it has received funding from SUSMED,Inc.	10/03/22
Shionogi Signs up to $41 Million Commercialization Contract for Insomnia App	28/12/21
Shionogi & Co., Ltd. Announces Commercialization Agreement with SUSMED Co., Ltd. for Digital Therapeutic App for Insomnia	27/12/21
SUSMED,Inc. has completed an IPO in the amount of ¥3.65613 billion.	24/12/21
SUSMED,Inc. has filed an IPO.	19/11/21
SUSMED Co., Ltd. announced that it has received funding from Suzuken Co., Ltd.	30/10/20
SUSMED Co., Ltd. announced that it expects to receive funding from Suzuken Co., Ltd.	27/10/20
SUSMED Co., Ltd. announced that it has received ¥200 million in funding from Sumitomo Corporation	25/08/20
SUSMED Co., Ltd. announced that it expects to receive funding from Suzuken Co., Ltd.	11/05/20
SUSMED Co., Ltd. announced that it has received ¥720 million in funding from Tokyo Century Corporation, M3, Inc., SBI Investment Co., Ltd., Beyond Next Ventures Inc., Sony Innovation Fund, The Dai-Ichi Life Insurance Company, Limited	04/06/18

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Tous les transcripts sur plus de 9000 sociétés, le jour de leur publication !

Débloquez-les Maintenant !

fermer